Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Biovail Announces First-Quarter 2007 Earnings Release, Conference-Call Details.


TORONTO -- Biovail Corporation (NYSE NYSE

See: New York Stock Exchange
:BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency
)(TSX TSX Toronto Stock Exchange (TSE before April, 2002)
TSX Transfer from Stack Pointer to Index
TSX True Space Extension
:BVF) today announced that it will host a conference call and Webcast on Thursday, May 10, 2007, at 8:30 a.m. EDT EDT
abbr.
Eastern Daylight Time


EDT Eastern Daylight Time

EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York

EDT 
, for Company executives to discuss first-quarter 2007 financial and operational results.

Following the discussion, Biovail executives will address inquiries from investment analysts.

A live Webcast of this call will be available through the Investor Relations Investor relations

The process by which the corporation communicates with its investors.
 section of Biovail's Web site at www.biovail.com. To access the call live, please dial 416-340-8010 (Toronto and International callers) and 1-866-540-8136 (U.S. and Canada). Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7 p.m. EDT on Thursday, May 17, 2007, by dialing 416-695-5800 (Toronto and International callers) and 1-800-408-3053 (U.S. and Canada), using access code, 3221188#.

About Biovail Corporation

Biovail Corporation is a specialty pharmaceutical company, engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products utilizing advanced drug-delivery technologies. For more information about Biovail, visit the Company's Web site at www.biovail.com.

For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Article Type:Financial report
Date:Apr 25, 2007
Words:200
Previous Article:Hospitals Protect Patients, Staff & Visitors from Spread of MRSA, Drug-Resistant Germs with Unotron's Washable Computer Keyboards and Mice.
Next Article:Reata's Synthetic Triterpenoids Profiled in Nature Reviews Cancer.
Topics:



Related Articles
Biovail Announces Fourth-Quarter, Full-Year 2005 Earnings Release, Conference-Call Details.
Biovail Announces First-Quarter 2006 Earnings Release, Conference-Call Details.
Biovail Reports First-Quarter 2006 Financial Results; Company Records Total Revenues of $220.5 Million; Operating Margins of 35.1%; EPS From...
Biovail Announces Second-Quarter 2006 Earnings Release, Conference-Call Details.
Biovail Updates 2006 Guidance.
Biovail Announces Third-Quarter 2006 Earnings Release, Conference-Call Details.
Biovail Updates 2006 Guidance.
Depomed Reports 2006 Year End Financial Results.
Depomed to Announce First Quarter 2007 Financial Results on Tuesday, May 8.
Depomed Reports First Quarter 2007 Financial Results.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles